Equitec Proprietary Markets »

Kinnate Biopharma shares owned by Equitec Proprietary Markets

Quarter-by-quarter ownership of Kinnate Biopharma (KNTE) shares owned by Equitec Proprietary Markets from 13F filings

Historical chart of Equitec Proprietary Markets investment in Kinnate Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Kinnate Biopharma held by Equitec Proprietary Markets consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kinnate Biopharma by Equitec Proprietary Markets

Quarter filed Position value Share count Share price at filing
2024-03-31 $536k 202k 2.66

More positions owned by Equitec Proprietary Markets

United States Steel Corporation Call Option (X)
Super Micro Computer Call Option (SMCI)
Applied Digital Corp Com New (APLD)
NVIDIA Corporation (NVDA)
B. Riley Financial (RILY)
Capri Holdings SHS (CPRI)
Microstrategy Cl A New (MSTR)
Fusion Pharmaceuticals Call Option (FUSN)
Amedisys (AMED)
Brookfield Infrastructure Com Sb Vtg Shs A (BIPC)
Vizio Hldg Corp Cl A Com (VZIO)
Angel Oak Finl Strategies In Com Ben Int (FINS)
Cannae Holdings (CNNE)
Doubledown Interactive Co Lt Ads (DDI)
American Equity Investment Life Holding (AEL)

View all positions for Equitec Proprietary Markets

Top funds holding Kinnate Biopharma

Foresite Capital Management IV
OrbiMed Advisors
Foresite Capital Management V
Lynx1 Capital Management
Viking Global Investors
Susquehanna International
Vanguard Group
Deltec Asset Management
Tang Capital Management
Acadian Asset Management
BML Capital Management
Yakira Capital Management
BlackRock
Group One Trading
GSA Capital Partners

View all funds holding Kinnate Biopharma